X4 Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €2.19M +∞% -€32.06M -63.0% -1,464.6% -15 pp -€111.78M +35.4% -5,106.6% -51 pp
    €0.00 +NaN% -€86.61M +7.8% N/A -€82.57M +25.3% N/A
    €0.00 +NaN% -€80.36M +5.8% N/A -€65.92M +9.5% N/A
    €0.00 -100.0% -€75.93M +42.8% N/A -€60.17M +22.3% N/A
    €2.57M +∞% -€53.19M +9.8% -2,071.0% -21 pp -€49.19M +20.0% -1,915.2% -19 pp
    €0.00 -100.0% -€48.46M +31.6% N/A -€40.99M +17.2% N/A
    €3.00M +∞% -€36.83M +27.0% -1,229.2% -12 pp -€34.99M +46.9% -1,167.7% -12 pp
    €0.00 +NaN% -€29.00M +47.5% N/A -€23.82M +29.0% N/A
    €0.00 +NaN% -€19.67M +73.8% N/A -€18.46M +102.6% N/A
    €0.00 -€11.32M N/A -€9.11M N/A

    Notifications